Know Cancer

or
forgot password

Faslodex International Observational Non-Interventional Study in Advanced Breast Cancer


N/A
N/A
N/A
Not Enrolling
Female
Breast Cancer

Thank you

Trial Information

Faslodex International Observational Non-Interventional Study in Advanced Breast Cancer


Inclusion Criteria:



- Postmenopausal women with hormone receptor-positive locally advanced or metastatic
breast cancer

- Ability to read and write and complete questionnaires

- Provision of written informed consent

- Patients who already received a prescription for fulvestrant

Exclusion Criteria:

- A subject who does not fulfil all the above mentioned inclusion criteria is not
allowed to participate in this NIS

Type of Study:

Observational

Study Design:

Observational Model: Case-Only, Time Perspective: Prospective

Outcome Measure:

Clinical Benefit, defined as the development of at least one of the following stages and holding on for at least 6 month: Complete response, partial response or stable disease

Outcome Time Frame:

Baseline, after 3, 6, 9 month

Safety Issue:

No

Principal Investigator

Guenther Steger, Univ Prof. Dr.

Investigator Role:

Study Chair

Investigator Affiliation:

Medical University of Vienna

Authority:

Austria: Ethikkommission

Study ID:

NIS-OAT-FAS-2009/1

NCT ID:

NCT00880711

Start Date:

April 2009

Completion Date:

December 2010

Related Keywords:

  • Breast Cancer
  • Fiona
  • Faslodex
  • Advanced Breast Cancer
  • Real life data
  • Collect real life data in clinical practice across Austria
  • Breast Neoplasms

Name

Location